Cargando…

Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia

Detalles Bibliográficos
Autores principales: McCall, David, Roth, Michael, Mahadeo, Kris M., Toepfer, Laurie, Nunez, Cesar, Short, Nicholas J., Daver, Naval, Kadia, Tapan M., DiNardo, Courtney, Yi, Joanna S., Cuglievan, Branko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153013/
https://www.ncbi.nlm.nih.gov/pubmed/34592761
http://dx.doi.org/10.1182/bloodadvances.2021005164
_version_ 1784717762142142464
author McCall, David
Roth, Michael
Mahadeo, Kris M.
Toepfer, Laurie
Nunez, Cesar
Short, Nicholas J.
Daver, Naval
Kadia, Tapan M.
DiNardo, Courtney
Yi, Joanna S.
Cuglievan, Branko
author_facet McCall, David
Roth, Michael
Mahadeo, Kris M.
Toepfer, Laurie
Nunez, Cesar
Short, Nicholas J.
Daver, Naval
Kadia, Tapan M.
DiNardo, Courtney
Yi, Joanna S.
Cuglievan, Branko
author_sort McCall, David
collection PubMed
description
format Online
Article
Text
id pubmed-9153013
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-91530132022-05-31 Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia McCall, David Roth, Michael Mahadeo, Kris M. Toepfer, Laurie Nunez, Cesar Short, Nicholas J. Daver, Naval Kadia, Tapan M. DiNardo, Courtney Yi, Joanna S. Cuglievan, Branko Blood Adv Research Letter American Society of Hematology 2021-12-07 /pmc/articles/PMC9153013/ /pubmed/34592761 http://dx.doi.org/10.1182/bloodadvances.2021005164 Text en © 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Research Letter
McCall, David
Roth, Michael
Mahadeo, Kris M.
Toepfer, Laurie
Nunez, Cesar
Short, Nicholas J.
Daver, Naval
Kadia, Tapan M.
DiNardo, Courtney
Yi, Joanna S.
Cuglievan, Branko
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
title Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
title_full Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
title_fullStr Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
title_full_unstemmed Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
title_short Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
title_sort gilteritinib combination therapies in pediatric patients with flt3-mutated acute myeloid leukemia
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153013/
https://www.ncbi.nlm.nih.gov/pubmed/34592761
http://dx.doi.org/10.1182/bloodadvances.2021005164
work_keys_str_mv AT mccalldavid gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT rothmichael gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT mahadeokrism gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT toepferlaurie gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT nunezcesar gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT shortnicholasj gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT davernaval gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT kadiatapanm gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT dinardocourtney gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT yijoannas gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia
AT cuglievanbranko gilteritinibcombinationtherapiesinpediatricpatientswithflt3mutatedacutemyeloidleukemia